Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
Gene-engineered immune cell therapies have partially transformed cancer treatment, as exemplified by the use of chimeric antigen receptor (CAR)-T cells in certain hematologic malignancies. However, there are several limitations that need to be addressed to target more cancer types. Natural killer (N...
Main Authors: | Eunju Shin, Seong Ho Bak, Taeho Park, Jin Woo Kim, Suk-Ran Yoon, Haiyoung Jung, Ji-Yoon Noh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1192907/full |
Similar Items
-
Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
by: Arum Park, et al.
Published: (2018-08-01) -
Natural Killer Cells and Immunotherapy
by: Ji-Yoon Noh, et al.
Published: (2023-05-01) -
Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
by: Ji-Yoon Noh, et al.
Published: (2020-10-01) -
Emerging Approaches for Solid Tumor Treatment Using CAR-T Cell Therapy
by: Hyunmin Chung, et al.
Published: (2021-11-01) -
Molecular Mechanisms and Emerging Therapeutics for Osteoporosis
by: Ji-Yoon Noh, et al.
Published: (2020-10-01)